---
figid: PMC5267446__12964_2017_163_Fig3_HTML
figlink: /pmc/articles/PMC5267446/figure/Fig3/
number: Fig. 3
caption: 'Non-canonical control of GLI activity by oncogenic mechanisms involving
  kinases, and epigenetic modulators. Rationale-based small-molecule targeting of
  these GLI regulatory signals with clinically approved/suitable drugs alone or in
  combination with HH pathway inhibitors such as direct GLI antagonists may generate
  efficient therapeutic effects. HPI-1: Hedgehog Pathway Inhibitor-1 acting at the
  level of GLI proteins [], GANT61: direct GLI antagonist 61 [], Glab B: glabrescione
  B (direct GLI inhibitor interfering with DNA binding) [], HDACi: HDAC inhibitors'
pmcid: PMC5267446
papertitle: Acute myeloid leukemia â€“ strategies and challenges for targeting oncogenic
  Hedgehog/GLI signaling.
reftext: Fritz Aberger, et al. Cell Commun Signal. 2017;15:8.
pmc_ranked_result_index: '21101'
pathway_score: 0.9678144
filename: 12964_2017_163_Fig3_HTML.jpg
figtitle: Acute myeloid leukemia and oncogenic Hedgehog/GLI signaling.
year: '2017'
organisms: Homo sapiens
ndex: e4a6e80c-de8d-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5267446__12964_2017_163_Fig3_HTML.html
  '@type': Dataset
  description: 'Non-canonical control of GLI activity by oncogenic mechanisms involving
    kinases, and epigenetic modulators. Rationale-based small-molecule targeting of
    these GLI regulatory signals with clinically approved/suitable drugs alone or
    in combination with HH pathway inhibitors such as direct GLI antagonists may generate
    efficient therapeutic effects. HPI-1: Hedgehog Pathway Inhibitor-1 acting at the
    level of GLI proteins [], GANT61: direct GLI antagonist 61 [], Glab B: glabrescione
    B (direct GLI inhibitor interfering with DNA binding) [], HDACi: HDAC inhibitors'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CSNK1A1
  - HDAC3
  - DYRK1B
  - MTOR
  - STAT5A
  - DNMT1
  - STAT5B
  - PIK3R3
  - MAPK1
  - FLT3
  - DYRK1A
  - PIK3R5
  - PIK3R4
  - BRAF
  - PIK3CG
  - MAP2K2
  - ARAF
  - SMO
  - PIK3R6
  - HDAC8
  - MAPK3
  - GLI1
  - BRD4
  - PIK3CB
  - PIK3CD
  - RAF1
  - HDAC2
  - MAP2K1
  - PIK3CA
  - HDAC1
  - PF-04449913
  - pyrvinium
  - GDC-0449
  - trametinib
  - sonidegib
  - cobimetinib
  - Cancer
genes:
- word: CK1A
  symbol: CK1a
  source: hgnc_alias_symbol
  hgnc_symbol: CSNK1A1
  entrez: '1452'
- word: HDACI
  symbol: HDAC_I
  source: bioentities_symbol
  hgnc_symbol: HDAC3
  entrez: '8841'
- word: DYRK1A/B
  symbol: DYRK1B
  source: hgnc_symbol
  hgnc_symbol: DYRK1B
  entrez: '9149'
- word: PI3K/MTOR/S6K
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: FLT3/STAT5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: DNMT
  symbol: DNMT
  source: hgnc_prev_symbol
  hgnc_symbol: DNMT1
  entrez: '1786'
- word: FLT3/STAT5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: PI3K/MTOR/S6K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: RTK/RAF/MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: FLT3/STAT5
  symbol: FLT3
  source: hgnc_symbol
  hgnc_symbol: FLT3
  entrez: '2322'
- word: DYRK1A/B
  symbol: DYRK1A
  source: hgnc_symbol
  hgnc_symbol: DYRK1A
  entrez: '1859'
- word: PI3K/MTOR/S6K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/MTOR/S6K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: RTK/RAF/MEK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PI3K/MTOR/S6K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: RTK/RAF/MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RTK/RAF/MEK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: SMO
  symbol: SMO
  source: hgnc_symbol
  hgnc_symbol: SMO
  entrez: '6608'
- word: PI3K/MTOR/S6K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: HDACI
  symbol: HDAC_I
  source: bioentities_symbol
  hgnc_symbol: HDAC8
  entrez: '55869'
- word: RTK/RAF/MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: GLI
  symbol: GLI
  source: hgnc_prev_symbol
  hgnc_symbol: GLI1
  entrez: '2735'
- word: BRD4
  symbol: BRD4
  source: hgnc_symbol
  hgnc_symbol: BRD4
  entrez: '23476'
- word: PI3K/MTOR/S6K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/MTOR/S6K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: RTK/RAF/MEK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: HDACI
  symbol: HDAC_I
  source: bioentities_symbol
  hgnc_symbol: HDAC2
  entrez: '3066'
- word: RTK/RAF/MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K/MTOR/S6K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: HDACI
  symbol: HDAC_I
  source: bioentities_symbol
  hgnc_symbol: HDAC1
  entrez: '3065'
chemicals:
- word: PF-04449913
  source: MESH
  identifier: C000592580
- word: pyrvinium
  source: MESH
  identifier: C024631
- word: GDC-0449
  source: MESH
  identifier: C538724
- word: trametinib
  source: MESH
  identifier: C560077
- word: sonidegib
  source: MESH
  identifier: C561435
- word: cobimetinib
  source: MESH
  identifier: C574276
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
